Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Global Oral Thin Film Drugs Markets, 2022-2030 with 2021 as the Base Year - Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts
February 10, 2023 06:08 ET
|
Research and Markets
Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Oral Thin Film Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Global Oral Thin Films Market Report to 2031 - Featuring ZIM Laboratories, NAL Pharma, Cure Pharmaceutical and IntelGenx Among Others
September 19, 2022 06:23 ET
|
Research and Markets
Dublin, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The "Oral Thin Films Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers...
Global Novel Drug Delivery Systems (NDDS) Market Outlook, 2026 - Microfluidics Mediated NDDS Set to Make Gains
February 07, 2022 06:58 ET
|
Research and Markets
Dublin, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The "Novel Drug Delivery Systems (NDDS) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Novel...
Worldwide Oral Thin Films Industry to 2026 - The Sublingual Film Segment Holds a Significant Share of the Market
December 29, 2021 08:53 ET
|
Research and Markets
Dublin, Dec. 29, 2021 (GLOBE NEWSWIRE) -- The "Oral Thin Films Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering. ...
CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
July 15, 2020 08:00 ET
|
CURE Pharmaceutical Holding Corp.
OXNARD, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD) oral thin film...
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on High Loading of Active Ingredient in Oral Thin Films
July 24, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
July 16, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....
CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films
June 19, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth...
CURE Pharmaceutical (OTCQB:CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
May 14, 2019 09:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has closed on the previously...
Meroven LLC and CURE Pharmaceutical Enter Exclusive Marketing and Distribution Agreement for Spee-D for the USA
May 02, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
CHICAGO, May 02, 2019 (GLOBE NEWSWIRE) -- Today, at the CPhI Conference, Meroven LLC announced a five-year agreement with CURE Pharmaceutical Corporation (OTCQB: CURR) to exclusively market and...